The Cool Down on MSN
Startup develops game-changing solution for major problem with common waste: 'I thought it was too good to be true'
A new startup is revolutionizing how textile and plastic waste are recycled, cutting costs and improving efficiency.
Circle Pharma, a clinical-stage biopharmaceutical company dedicated to discovering and developing cell-permeable macrocycles as a new class of therapies, today announced the successful closing of a ...
Allschwil, Switzerland, July 31, 2013 - Polyphor, a research-driven pharmaceutical company and leader in the discovery and development of macrocyclic drugs, today announced that Boehringer Ingelheim ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Circle Pharma, a clinical-stage biopharmaceutical company dedicated to discovering and developing a new generation of macrocycle therapies, today ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Circle Pharma, a clinical-stage biopharmaceutical company dedicated to discovering and developing a new generation of macrocycle therapies, today ...
Circle Pharma, Inc., a clinical-stage biopharmaceutical company pioneering next-generation targeted macrocycle therapeutics for difficult-to-treat cancers, today announced an agreement with Eli Lilly ...
Circle Pharma, a clinical-stage biopharmaceutical company advancing macrocycle therapeutics for difficult-to-treat cancers, today announced that its Trials in Progress abstract has been selected for ...
- Startup emerges from Versant’s Frontier Discovery Engine with over $70 million in capital to develop oral macrocyclic peptides - Biogen and Dayra partnership will identify, validate and optimize ...
Have updates? Send them our way! You know your company best! If there is information about your company that you’d like changed, please fill out the linked form to submit an update.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback